Natco Pharma Limited — Updates, 25-08-2026: Press Release
25-08-2026 | 12:18 pm
25-08-2026 | 12:18 pm
Natco Pharma invested an additional US$ 14 million in eGenesis, Inc., bringing its total investment to US$ 22 million. eGenesis pioneers genome engineering for transplantable organs, addressing global organ shortages.
No comments yet. Be the first to comment!
